Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02610361
Title Study of the Safety and Pharmacokinetics of BGB-283 in Patients With Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors BeiGene
Indications
Therapies
Age Groups: adult
Covered Countries NZL | AUS

Facility Status City State Zip Country Details
Chris Obrien Lifehouse Camperdown New South Wales 2050 Australia Details
North Coast Cancer Institute Macquarie New South Wales 2444 Australia Details
Prince of Wales Hospital Randwick New South Wales 2031 Australia Details
Westmead Hospital Westmead New South Wales 2145 Australia Details
Princess Alexandra Hospital Brisbane Queensland 4102 Australia Details
Tasman Oncology Research Ltd Southport Gold Coast Queensland 4216 Australia Details
Royal Adelaide Hospital Adelaide South Australia 5000 Australia Details
Monash Health Clayton Victoria 3168 Australia Details
Austin Health Heidelberg Victoria 3084 Australia Details
Cabrini Hospital Malvern Malvern Victoria 3144 Australia Details
Peter Maccallum Cancer Centre Melbourne Victoria 3000 Australia Details
Alfred Cancer Trials Melbourne Victoria 3004 Australia Details
Royal Melbourne Hospital Parkville Victoria 3052 Australia Details
Linear Clinical Research Nedlands Western Australia 6009 Australia Details
Christchurch Hospital Christchurch 8011 New Zealand Details
Dunedin Hospital Dunedin 9016 New Zealand Details
Waikato Hospital Hamilton Waikato 3204 New Zealand Details
Wellington Regional Hospital (Ccdhb) Wellington 6021 New Zealand Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field